Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MF59-adjuvanted Influenza Vaccine in Children
NCT01342796Phase 2Completed
- Sponsor
- Novartis
- Start
- May 2011
- Primary completion
- Feb 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of influenza vaccine (surface antigen, inactivated, adjuvanted) in influenza, sponsored by Novartis. Started May 2011; status: completed.
02
Drugs
influenza vaccine (surface antigen, inactivated, adjuvanted)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01342796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01342796.